Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients

Molecular Oncology

Volumn 8, Issue 5, 2014, Pages 1014-1025

  de Kruijf, Esther M ^a   Bastiaannet, Esther ^a   Rubertá, Francesca ^a   de Craen, Anton J M ^a   Kuppen, Peter J K ^a   Smit, Vincent T H B M ^a   van de Velde, Cornelis J H ^a   Liefers, Gerrit Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Elderly; Molecular subtypes; Prognostication

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; RNA; GENETIC MARKER; TRANSCRIPTOME; BIOLOGICAL MARKER;

AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; AGE; BREAST; BREAST NEOPLASMS; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; ADULT; CANCER CLASSIFICATION; RECURRENCE FREE SURVIVAL;

AGE FACTORS; AGED; BREAST; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; MIDDLE AGED; TRANSCRIPTOME;

EID: 84903530107     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.03.022     Document Type: Article

References (31)

1. Anderson W.F., Jatoi I., Sherman M.E. Qualitative age interactions in breast cancer studies: mind the gap. J. Clin. Oncol. 2009, 27:5308-5311.
2. Aw D., Silva A.B., Palmer D.B. Immunosenescence: emerging challenges for an ageing population. Immunology 2007, 120:435-446.
3. Bastiaannet E., Liefers G.J., de Craen A.J., Kuppen P.J., van de Water W., Portielje J.E., van der Geest L.G., Janssen-Heijnen M.L., Dekkers O.M., van de Velde C.J., Westendorp R.G. Breast cancer in elderly compared to younger patients in The Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res. Treat. 2010, 124:801-807.
4. Bastiaannet E., Portielje J.E., van de V., de Craen A.J., van de V., Kuppen P.J., van der Geest L.G., Janssen-Heijnen M.L., Dekkers O.M., Westendorp R.G., Liefers G.J. Lack of survival gain for elderly women with breast cancer. Oncologist 2011, 16:415-423.
5. Beadle B.M., Woodward W.A., Buchholz T.A. The impact of age on outcome in early-stage breast cancer. Semin. Radiat. Oncol. 2011, 21:26-34.
6. Campos C., Pera A., Sanchez-Correa B., Alonso C., Lopez-Fernandez I., Morgado S., Tarazona R., Solana R. Effect of age and CMV on NK cell subpopulations. Exp. Gerontol. 2014 Jan 17, pii:S0531-5565(14)00011-4. http://dx.doi.org/10.1016/j.exger.2014.01.008. [Epub ahead of print].
7. Carey L.A., Perou C.M., Livasy C.A., Dressler L.G., Cowan D., Conway K., Karaca G., Troester M.A., Tse C.K., Edmiston S., Deming S.L., Geradts J., Cheang M.C., Nielsen T.O., Moorman P.G., Earp H.S., Millikan R.C. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006, 295:2492-2502.
8. Daidone M.G., Coradini D., Martelli G., Veneroni S. Primary breast cancer in elderly women: biological profile and relation with clinical outcome. Crit. Rev. Oncol. Hematol. 2003, 45:313-325.
9. de Kruijf E.M., van Nes J.G., Sajet A., Tummers Q.R., Putter H., Osanto S., Speetjens F.M., Smit V.T., Liefers G.J., van de Velde C.J., Kuppen P.J. The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer. Clin. Cancer Res. 2010, 16:1272-1280.
10. Diab S.G., Elledge R.M., Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. J. Natl. Cancer Inst. 2000, 92:550-556.
11. Du P., Kibbe W.A., Lin S.M. Lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24:1547-1548.
12. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717. Early Breast Cancer Trialists' Collaborative Group.
13. Eppenberger-Castori S., Moore D.H., Thor A.D., Edgerton S.M., Kueng W., Eppenberger U., Benz C.C. Age-associated biomarker profiles of human breast cancer. Int. J. Biochem. Cell Biol. 2002, 34:1318-1330.
14. Fulop T., Kotb R., Fortin C.F., Pawelec G., de A.F., Larbi A. Potential role of immunosenescence in cancer development. Ann. N. Y. Acad. Sci. 2010, 1197:158-165.
15. Gayoso I., Sanchez-Correa B., Campos C., Alonso C., Pera A., Casado J.G., Morgado S., Tarazona R., Solana R. Immunosenescence of human natural killer cells. J. Innate. Immun. 2011, 3:337-343.
16. Goldhirsch A., Wood W.C., Gelber R.D., Coates A.S., Thurlimann B., Senn H.J. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann. Oncol. 2007, 18:1133-1144.
17. Naumova E., Ivanova M., Pawelec G. Immunogenetics of ageing. Int. J. Immunogenet. 2011, 38:373-381.
18. Nielsen T.O., Hsu F.D., Jensen K., Cheang M., Karaca G., Hu Z., Hernandez-Boussard T., Livasy C., Cowan D., Dressler L., Akslen L.A., Ragaz J., Gown A.M., Gilks C.B., van de R.M., Perou C.M. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin. Cancer Res. 2004, 10:5367-5374.
19. Nixon A.J., Neuberg D., Hayes D.F., Gelman R., Connolly J.L., Schnitt S., Abner A., Recht A., Vicini F., Harris J.R. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J. Clin. Oncol. 1994, 12:888-894.
20. Pawelec G., Akbar A., Caruso C., Solana R., Grubeck-Loebenstein B., Wikby A. Human immunosenescence: is it infectious?. Immunol. Rev. 2005, 205:257-268.
21. Perou C.M., Sorlie T., Eisen M.B., van de R.M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S.X., Lonning P.E., Borresen-Dale A.L., Brown P.O., Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
22. Petrakis I.E., Paraskakis S. Breast cancer in the elderly. Arch. Gerontol. Geriatr. 2010, 50:179-184.
23. Putter H., Fiocco M., Geskus R.B. Tutorial in biostatistics: competing risks and multi-state models. Stat. Med. 2007, 26:2389-2430.
24. Remvikos Y., Magdelenat H., Dutrillaux B. Genetic evolution of breast cancers. III: Age-dependent variations in the correlations between biological indicators of prognosis. Breast Cancer Res. Treat. 1995, 34:25-33.
25. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de R.M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Eystein L.P., Borresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10869-10874.
26. Sorlie T., Tibshirani R., Parker J., Hastie T., Marron J.S., Nobel A., Deng S., Johnsen H., Pesich R., Geisler S., Demeter J., Perou C.M., Lonning P.E., Brown P.O., Borresen-Dale A.L., Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8418-8423.
27. Teschendorff A.E., Menon U., Gentry-Maharaj A., Ramus S.J., Weisenberger D.J., Shen H., Campan M., Noushmehr H., Bell C.G., Maxwell A.P., Savage D.A., Mueller-Holzner E., Marth C., Kocjan G., Gayther S.A., Jones A., Beck S., Wagner W., Laird P.W., Jacobs I.J., Widschwendter M. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010, 20:440-446.
28. Thomas G.A., Leonard R.C. How age affects the biology of breast cancer. Clin. Oncol. (R. Coll. Radiol.) 2009, 21:81-85.
29. van de W.W., Markopoulos C., van de V., Seynaeve C., Hasenburg A., Rea D., Putter H., Nortier J.W., de Craen A.J., Hille E.T., Bastiaannet E., Hadji P., Westendorp R.G., Liefers G.J., Jones S.E. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 2012, 307:590-597.
30. van Nes J.G., de Kruijf E.M., Faratian D., van de Velde C.J., Putter H., Falconer C., Smit V.T., Kay C., van de Vijver M.J., Kuppen P.J., Bartlett J.M. COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients. Breast Cancer Res. Treat. 2011 Feb, 125(3):671-685. [Epub 2010 Apr 1]. 10.1007/s10549-010-0854-7.
31. Wildiers H., Kunkler I., Biganzoli L., Fracheboud J., Vlastos G., Bernard-Marty C., Hurria A., Extermann M., Girre V., Brain E., Audisio R.A., Bartelink H., Barton M., Giordano S.H., Muss H., Aapro M. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol. 2007, 8:1101-1115.